Thomas Reiner

Title: Innovations in Imaging: The Contributions of Thomas Reiner

Introduction

Thomas Reiner is a prominent inventor based in Weehawken, NJ, known for his significant contributions to the field of medical imaging. With a total of seven patents to his name, Reiner has developed innovative techniques that enhance the detection and treatment of cancer. His work focuses on improving imaging strategies that allow for earlier diagnosis and reduced radiation exposure to healthy tissues.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Radioligands for pretargeted PET imaging and methods of their therapeutic use." This patent describes Tz/TCO-based pretargeting strategies utilizing an Al[F]-NOTA-labeled tetrazine radioligand. This imaging strategy enables the delineation of cancer at earlier time points compared to other imaging methods, significantly decreasing the radiation dose to healthy tissues when compared to directly labeled antibodies. Additionally, Reiner's work on "Compositions and methods for in vivo imaging" relates to compounds useful for targeting PARP1, providing methods for detecting and imaging cancer cells.

Career Highlights

Throughout his career, Thomas Reiner has worked with esteemed institutions such as the General Hospital Corporation and Memorial Sloan Kettering Cancer Center. His innovative approaches have made a lasting impact on the field of cancer imaging and treatment.

Collaborations

Reiner has collaborated with notable professionals in his field, including Edmund J. Keliher and Ralph Weissleder. These collaborations have further advanced the research and development of imaging technologies.

Conclusion

Thomas Reiner's contributions to medical imaging through his patents and collaborations have significantly enhanced cancer detection and treatment methodologies. His innovative work continues to pave the way for advancements in the field.